Zobrazeno 1 - 10
of 25
pro vyhledávání: '"J. F. Johanson"'
Publikováno v:
Digestive Diseases and Sciences. 56:767-772
Background The sensitivity of screening for Barrett’s esophagus (BE) and esophageal dysplasia (ED) is hampered by the limited amount of tissue that can be sampled by forceps biopsy (FB). Aim The aim of this study was to evaluate computer assisted a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::175f023d125c3dbcac5c535384b8b3c3
https://doi.org/10.1007/s10620-010-1497-6
https://doi.org/10.1007/s10620-010-1497-6
Publikováno v:
Alimentary Pharmacology & Therapeutics. 27:685-696
SUMMARY Background Analyses of a trial in constipated patients indicated that lubiprostone may be an effective treatment for irritable bowel syndrome with constipation. Aim To assess the efficacy and safety of three lubiprostone doses for irritable b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::baacca032537efae7e91f35d48ff73f2
https://doi.org/10.1111/j.1365-2036.2008.03629.x
https://doi.org/10.1111/j.1365-2036.2008.03629.x
Publikováno v:
Alimentary Pharmacology & Therapeutics. 26:1101-1111
Summary Background The use of non-steroidal anti-inflammatory drugs (NSAID) is associated with an increased risk of gastric ulcer (GU) development. Methods This multicentre, randomized, double-blind, parallel-group trial compared endoscopic healing r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f544c37cce03bd94d783d509549300fb
https://doi.org/10.1111/j.1365-2036.2007.03460.x
https://doi.org/10.1111/j.1365-2036.2007.03460.x
Autor:
J. F. Johanson, Ryuji Ueno
Publikováno v:
Alimentary Pharmacology & Therapeutics. 25:1351-1361
Summary Background Lubiprostone, a locally acting type-2 chloride channel activator, induces intestinal fluid secretion. Aim To assess efficacy and safety of oral lubiprostone at multiple doses for the treatment of chronic constipation. Methods A tot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e70ac6f09cf674ead982e8e77e3c7fa7
https://doi.org/10.1111/j.1365-2036.2007.03320.x
https://doi.org/10.1111/j.1365-2036.2007.03320.x
Autor:
G. H. Guyatt, Maria José Martinez-Zapata, Edward J Mills, Pablo Alonso-Coello, Diane Heels-Ansdell, Qi Zhou, J. F. Johanson
Publikováno v:
British Journal of Surgery. 93:909-920
Background The aim of the study was to evaluate the impact of flavonoids on those symptoms important to patients with symptomatic haemorrhoids. Methods A comprehensive search strategy was used. All published and unpublished randomized controlled tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b30cb431827159f9c0f44f73e337a305
https://doi.org/10.1002/bjs.5378
https://doi.org/10.1002/bjs.5378
Autor:
J. F. Johanson
Publikováno v:
Neurogastroenterology and Motility. 16:701-711
This article reviews the efficacy and toler- ability of traditional therapies for irritable bowel syn- drome (IBS) and concludes that they are limited by both poor efficacy and adverse effects. Serotonin, a neurotransmitter found mainly in the gut, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d40a2f098b1049dc8e041d6fcbe1ff0b
https://doi.org/10.1111/j.1365-2982.2004.00550.x
https://doi.org/10.1111/j.1365-2982.2004.00550.x
Autor:
J F Johanson, Hashem B. El-Serag
Publikováno v:
Scandinavian Journal of Gastroenterology. 37:899-904
The risk factors for the varying grades of erosive esophagitis (EE) severity could be better understood. For that reason. we evaluated the risk factors associated with EE in patients with gastroesophageal reflux disease.We determined the presence and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::732820147e9cfbef8c82b4a5d6f07e44
https://doi.org/10.1080/003655202760230847
https://doi.org/10.1080/003655202760230847
Publikováno v:
Alimentary pharmacologytherapeutics. 27(8)
Analyses of a trial in constipated patients indicated that lubiprostone may be an effective treatment for irritable bowel syndrome with constipation.To assess the efficacy and safety of three lubiprostone doses for irritable bowel syndrome with const
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8fe14a7dd76b85449819a1de614d7577
https://pubmed.ncbi.nlm.nih.gov/18248656
https://pubmed.ncbi.nlm.nih.gov/18248656
Publikováno v:
Alimentary pharmacologytherapeutics. 26(8)
The use of non-steroidal anti-inflammatory drugs (NSAID) is associated with an increased risk of gastric ulcer (GU) development.This multicentre, randomized, double-blind, parallel-group trial compared endoscopic healing rates at 4 and 8 weeks after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1f82450b09f9a6c18f18d39411ba85ca
https://pubmed.ncbi.nlm.nih.gov/17894652
https://pubmed.ncbi.nlm.nih.gov/17894652
Autor:
J F, Johanson, R, Ueno
Publikováno v:
Alimentary pharmacologytherapeutics. 25(11)
Lubiprostone, a locally acting type-2 chloride channel activator, induces intestinal fluid secretion.To assess efficacy and safety of oral lubiprostone at multiple doses for the treatment of chronic constipation.A total of 129 patients with chronic c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a24ca4c345e566b9882dfe9d5dfc3fd3
https://pubmed.ncbi.nlm.nih.gov/18166366
https://pubmed.ncbi.nlm.nih.gov/18166366